The protective role of curcumin in mitigating drug-induced toxicity in male reproductive system
Abstract
Background: Curcumin, a key bioactive component of turmeric (Curcuma longa L. [Zingiberaceae]), has gained considerable attention for its potential to mitigate drug-induced toxicity. This review synthesizes and clarifies current findings on curcumin's ability to prevent the adverse effects of various pharmaceuticals.
Methods: A comprehensive search using multiple databases-PubMed®, Scopus®, ScienceDirect®, and Web of Science®-was conducted for articles published up to October 2023. The current review is limited to randomized controlled trials, observational studies, and animal studies investigating the protective role of curcumin against drug-induced toxicity. The data extraction process included a variety of study characteristics, types of drugs used, curcumin dosing regimens, and reported outcomes associated with drug-induced toxicity.
Results: A total of twenty-five studies were reviewed for this analysis. Curcumin may help reduce the side effects of certain medications, including sertraline, diclofenac, paclitaxel, irinotecan, and methotrexate.
Discussion: Research also indicates that curcumin possesses antioxidant properties, reduces inflammation, and aids sperm production. Most importantly, sperm motility, density, and morphology significantly improved in curcumin-treated groups compared to the control groups undergoing toxic pharmaceutical treatment. The dosage of curcumin used in these studies ranges from 50 to 200 mg/kg body weight.
Conclusion: The available…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.